Innovative multidimensional models in a high-throughput-format for different cell types of endocrine origin.


Journal

Cell death & disease
ISSN: 2041-4889
Titre abrégé: Cell Death Dis
Pays: England
ID NLM: 101524092

Informations de publication

Date de publication:
25 07 2022
Historique:
received: 14 04 2022
accepted: 12 07 2022
revised: 08 07 2022
entrez: 25 7 2022
pubmed: 26 7 2022
medline: 28 7 2022
Statut: epublish

Résumé

The adrenal gland provides an important function by integrating neuronal, immune, vascular, metabolic and endocrine signals under a common organ capsule. It is the central organ of the stress response system and has been implicated in numerous stress-related disorders. While for other diseases, regeneration of healthy organ tissue has been aimed at such approaches are lacking for endocrine diseases - with the exception of type-I-diabetes. Moreover, adrenal tumor formation is very common, however, appropriate high-throughput applications reflecting the high heterogeneity and furthermore relevant 3D-structures in vitro are still widely lacking. Recently, we have initiated the development of standardized multidimensional models of a variety of endocrine cell/tissue sources in a new multiwell-format. Firstly, we confirmed common applicability for pancreatic pseudo-islets. Next, we translated applicability for spheroid establishment to adrenocortical cell lines as well as patient material to establish spheroids from malignant, but also benign adrenal tumors. We aimed furthermore at the development of bovine derived healthy adrenal organoids and were able to establish steroidogenic active organoids containing both, cells of cortical and medullary origin. Overall, we hope to open new avenues for basic research, endocrine cancer and adrenal tissue-replacement-therapies as we demonstrate potential for innovative mechanistic insights and personalized medicine in endocrine (tumor)-biology.

Identifiants

pubmed: 35879289
doi: 10.1038/s41419-022-05096-x
pii: 10.1038/s41419-022-05096-x
pmc: PMC9314441
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

648

Informations de copyright

© 2022. The Author(s).

Références

Front Bioeng Biotechnol. 2019 Dec 03;7:380
pubmed: 31850335
Cell. 2014 Sep 25;159(1):176-187
pubmed: 25201530
Cancers (Basel). 2020 Apr 09;12(4):
pubmed: 32283844
Mol Cell Endocrinol. 2019 Dec 1;498:110585
pubmed: 31536779
Int J Cancer. 2018 Jul 1;143(1):199-211
pubmed: 29411361
Diabetes. 2007 Mar;56(3):594-603
pubmed: 17327426
Front Endocrinol (Lausanne). 2020 Apr 16;11:219
pubmed: 32373071
J Clin Endocrinol Metab. 2020 Sep 1;105(9):
pubmed: 32629476
J Tissue Eng Regen Med. 2017 Jan;11(1):109-120
pubmed: 24737702
Endocr Relat Cancer. 2020 Dec;27(12):R433-R450
pubmed: 33112800
Nat Rev Endocrinol. 2021 Jan;17(1):7-8
pubmed: 33087845
Gut. 2021 Mar;70(3):485-498
pubmed: 32503845
Oncotarget. 2016 Nov 29;7(48):79292-79304
pubmed: 27764813
J Clin Endocrinol Metab. 2016 Dec;101(12):4574-4584
pubmed: 27603910
Diabetes. 2021 May;70(5):1051-1060
pubmed: 33947722
Methods Cell Biol. 2010;96:395-423
pubmed: 20869532
Horm Metab Res. 2013 Feb;45(2):124-9
pubmed: 23111829
Dev Dyn. 2020 Mar;249(3):328-341
pubmed: 31794137
Cancer Discov. 2019 Jul;9(7):852-871
pubmed: 31053628
Endocr Relat Cancer. 2020 Jun;27(6):361-373
pubmed: 32276262
Proc Natl Acad Sci U S A. 2015 Feb 24;112(8):2527-32
pubmed: 25675525
Front Endocrinol (Lausanne). 2021 Apr 26;12:669426
pubmed: 33981288
FASEB J. 2019 Feb;33(2):2263-2277
pubmed: 30247985
Eur J Endocrinol. 2021 May 04;184(6):823-835
pubmed: 33830941
Macromol Biosci. 2020 Jan;20(1):e1900178
pubmed: 31596553
Front Endocrinol (Lausanne). 2019 Jul 19;10:487
pubmed: 31379752
Pharmaceutics. 2020 Dec 06;12(12):
pubmed: 33291351
Cells. 2022 Apr 24;11(9):
pubmed: 35563746
Cell. 2018 Jan 11;172(1-2):373-386.e10
pubmed: 29224780
Cell Rep. 2020 Jun 16;31(11):107762
pubmed: 32553164
Curr Opin Genet Dev. 2019 Feb;54:7-11
pubmed: 30844513
J Steroid Biochem Mol Biol. 2015 Jan;145:75-84
pubmed: 25312486
Nat Commun. 2021 Jun 10;12(1):3534
pubmed: 34112801
Am J Transplant. 2019 Jul;19(7):1930-1940
pubmed: 30748094
Curr Opin Endocr Metab Res. 2019 Oct;8:139-144
pubmed: 32550272
Urol Int. 2019;103(3):344-349
pubmed: 31434089

Auteurs

Stefan Bornstein (S)

Department of Endocrinology, Diabetology and Clinical Nutrition, University Hospital Zurich (USZ) and University of Zurich (UZH), Zurich, Switzerland.
Medizinische Klinik und Poliklinik III, University Hospital Carl Gustav Carus Dresden, Dresden, Germany.

Igor Shapiro (I)

Department of Endocrinology, Diabetology and Clinical Nutrition, University Hospital Zurich (USZ) and University of Zurich (UZH), Zurich, Switzerland.

Maria Malyukov (M)

Medizinische Klinik und Poliklinik III, University Hospital Carl Gustav Carus Dresden, Dresden, Germany.

Richard Züllig (R)

Department of Endocrinology, Diabetology and Clinical Nutrition, University Hospital Zurich (USZ) and University of Zurich (UZH), Zurich, Switzerland.

Edlira Luca (E)

Department of Endocrinology, Diabetology and Clinical Nutrition, University Hospital Zurich (USZ) and University of Zurich (UZH), Zurich, Switzerland.

Evgeny Gelfgat (E)

Medizinische Klinik und Poliklinik III, University Hospital Carl Gustav Carus Dresden, Dresden, Germany.

Felix Beuschlein (F)

Department of Endocrinology, Diabetology and Clinical Nutrition, University Hospital Zurich (USZ) and University of Zurich (UZH), Zurich, Switzerland.
Endocrine Research Unit, Medizinische Klinik und Poliklinik IV, Klinikum der Universität München, 80336, Munich, Germany.

Svenja Nölting (S)

Department of Endocrinology, Diabetology and Clinical Nutrition, University Hospital Zurich (USZ) and University of Zurich (UZH), Zurich, Switzerland.
Department of Medicine IV, University Hospital, LMU Munich, Ziemssenstraße 1, 80336, München, Germany.

Alfredo Berruti (A)

Oncology Unit, Department of Medical and Surgical Specialties, Radiological Sciences, and Public Health, University of Brescia at ASST Spedali Civili di Brescia, 25123, Brescia, Italy.

Sandra Sigala (S)

Section of Pharmacology, Department of Molecular and Translational Medicine, University of Brescia, 25123, Brescia, Italy.

Mirko Peitzsch (M)

Medizinische Klinik und Poliklinik III, University Hospital Carl Gustav Carus Dresden, Dresden, Germany.
Institute of Clinical Chemistry and Laboratory Medicine, University Hospital Carl Gustav Carus at Technische Universität Dresden, Dresden, Germany.

Charlotte Steenblock (C)

Medizinische Klinik und Poliklinik III, University Hospital Carl Gustav Carus Dresden, Dresden, Germany.

Barbara Ludwig (B)

Department of Endocrinology, Diabetology and Clinical Nutrition, University Hospital Zurich (USZ) and University of Zurich (UZH), Zurich, Switzerland.
Medizinische Klinik und Poliklinik III, University Hospital Carl Gustav Carus Dresden, Dresden, Germany.

Patrick Kugelmeier (P)

Kugelmeiers AG, Erlenbach, Switzerland.

Constanze Hantel (C)

Department of Endocrinology, Diabetology and Clinical Nutrition, University Hospital Zurich (USZ) and University of Zurich (UZH), Zurich, Switzerland. Constanze.Hantel@usz.ch.
Medizinische Klinik und Poliklinik III, University Hospital Carl Gustav Carus Dresden, Dresden, Germany. Constanze.Hantel@usz.ch.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH